Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Wegovy is approved for chronic weight management in obese and overweight individuals with at least one weight-related condition, such as type 2 diabetes mellitus, high blood pressure, and dyslipidemia
The information should not be considered complete and should not be used in place of a visit, phone or telemedicine call, consultation or advice of your physician or other healthcare provider
If approved, treatment with Retatrutide may be suitable for: Adults who are Overweight: BMI 27 with related health conditions such as fatty liver disease, type 2 diabetes, sleep apnea, high blood pressure, or high cholesterol
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mortality and Cardiovascular Events: A Comprehensive Meta-Analysis of Randomized Controlled Trials
US$ 20.88
US$ 24.99
US$ 25.63
US$ 25.33
US$ 27.15
US$ 22.85
